Cargando…
Detection of novel Fabry disease‐associated pathogenic variants in Japanese patients by newborn and high‐risk screening
BACKGROUND: In Japan, newborn and high‐risk screening for Fabry disease (FD), an inherited X‐linked disorder caused by GLA mutations, using dried blood spots was initiated in 2006. In newborn screening, 599,711 newborns were screened by December 2018, and 57 newborns from 54 families with 26 FD‐asso...
Autores principales: | Sawada, Takaaki, Kido, Jun, Sugawara, Keishin, Matsumoto, Shirou, Takada, Fumio, Tsuboi, Kazuya, Ohtake, Akira, Endo, Fumio, Nakamura, Kimitoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667298/ https://www.ncbi.nlm.nih.gov/pubmed/33016649 http://dx.doi.org/10.1002/mgg3.1502 |
Ejemplares similares
-
Fabry disease screening in high-risk populations in Japan: a nationwide study
por: Yoshida, Shinichiro, et al.
Publicado: (2020) -
Newborn screening for Fabry disease in the western region of Japan
por: Sawada, Takaaki, et al.
Publicado: (2020) -
Pathogenic variants of ornithine transcarbamylase deficiency: Nation-wide study in Japan and literature review
por: Kido, Jun, et al.
Publicado: (2022) -
Newborn screening for Gaucher disease in Japan
por: Sawada, Takaaki, et al.
Publicado: (2022) -
Current status of newborn screening for Pompe disease in Japan
por: Sawada, Takaaki, et al.
Publicado: (2021)